BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31364899)

  • 1. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
    Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
    Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Multiple Treatment Planning Techniques for High-Grade Glioma Tumors Near to Critical Organs.
    Bas Ayata H; Ceylan C; Kılıç A; Güden M; Engin K
    Oncol Res Treat; 2018; 41(9):514-519. PubMed ID: 30086547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of Risk of Normal-tissue Toxicity Following Gastric Cancer Radiotherapy with Photon- or Scanned Proton-beams.
    Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
    Anticancer Res; 2018 May; 38(5):2619-2625. PubMed ID: 29715081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation.
    Toussaint L; Indelicato DJ; Holgersen KS; Petersen JBB; Stokkevåg CH; Lassen-Ramshad Y; Casares-Magaz O; Vestergaard A; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1451-1456. PubMed ID: 31303090
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
    Walser MA; Bachmann N; Kluckert J; Köthe A; Tully C; Leiser D; Lomax AJ; Bizzocchi N; Langendijk JA; Weber DC
    Br J Radiol; 2023 Aug; 96(1148):20220672. PubMed ID: 37129312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
    Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
    Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
    Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
    Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
    De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
    Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors.
    Park J; Park Y; Lee SU; Kim T; Choi YK; Kim JY
    Radiat Oncol; 2015 Jun; 10():135. PubMed ID: 26112360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
    Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
    Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
    Beltran C; Roca M; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
    Cartechini G; Fracchiolla F; Menegotti L; Scifoni E; La Tessa C; Schwarz M; Farace P; Tommasino F
    Radiat Oncol; 2020 Oct; 15(1):228. PubMed ID: 33008412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
    Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
    Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.